 | • レポートコード：GIR-2104Z07969 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、IV・経口鉄剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。IV・経口鉄剤の種類別市場規模（経口鉄剤、IV鉄剤）、用途別市場規模（腎臓、OBGYN、手術、胃腸病、腫瘍、心不全（HF））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・IV・経口鉄剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Daiichi Sankyo Company、Vifor Pharma、Akebia Therapeutics、Allergan、AMAG Pharmaceuticals、AOP Orphan Pharmaceuticals、Pharmacosmos、Sanofi、Shield Therapeutics、AZAD Pharma、Cirondrugs、MEDICE、Pfizer、Salveo Lifecare、Sunny Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口鉄剤、IV鉄剤 ・用途別分析2016年-2026年：腎臓、OBGYN、手術、胃腸病、腫瘍、心不全（HF） ・IV・経口鉄剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・IV・経口鉄剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・IV・経口鉄剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・IV・経口鉄剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・IV・経口鉄剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The IV and Oral Iron Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global IV and Oral Iron Drugs size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global IV and Oral Iron Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
IV and Oral Iron Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral Iron Drug
IVIron Drugs
Market segment by Application, can be divided into
Nephrology
OBGYN
Surgeries
Gastroenterology
Oncology
Heart failure (HF)
Market segment by players, this report covers
Daiichi Sankyo Company
Vifor Pharma
Akebia Therapeutics
Allergan
AMAG Pharmaceuticals
AOP Orphan Pharmaceuticals
Pharmacosmos
Sanofi
Shield Therapeutics
AZAD Pharma
Cirondrugs
MEDICE
Pfizer
Salveo Lifecare
Sunny Pharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of IV and Oral Iron Drugs
1.2 Classification of IV and Oral Iron Drugs by Type
1.2.1 Overview: Global IV and Oral Iron Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global IV and Oral Iron Drugs Revenue Market Share by Type in 2020
1.2.3 Oral Iron Drug
1.2.4 IVIron Drugs
1.3 Global IV and Oral Iron Drugs Market by Application
1.3.1 Overview: Global IV and Oral Iron Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Nephrology
1.3.3 OBGYN
1.3.4 Surgeries
1.3.5 Gastroenterology
1.3.6 Oncology
1.3.7 Heart failure (HF)
1.4 Global IV and Oral Iron Drugs Market Size & Forecast
1.5 Global IV and Oral Iron Drugs Market Size and Forecast by Region
1.5.1 Global IV and Oral Iron Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global IV and Oral Iron Drugs Market Size by Region, (2016-2021)
1.5.3 North America IV and Oral Iron Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe IV and Oral Iron Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific IV and Oral Iron Drugs Market Size and Prospect (2016-2026)
1.5.6 South America IV and Oral Iron Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa IV and Oral Iron Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 IV and Oral Iron Drugs Market Drivers
1.6.2 IV and Oral Iron Drugs Market Restraints
1.6.3 IV and Oral Iron Drugs Trends Analysis
2 Company Profiles
2.1 Daiichi Sankyo Company
2.1.1 Daiichi Sankyo Company Details
2.1.2 Daiichi Sankyo Company Major Business
2.1.3 Daiichi Sankyo Company IV and Oral Iron Drugs Product and Solutions
2.1.4 Daiichi Sankyo Company IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Daiichi Sankyo Company Recent Developments and Future Plans
2.2 Vifor Pharma
2.2.1 Vifor Pharma Details
2.2.2 Vifor Pharma Major Business
2.2.3 Vifor Pharma IV and Oral Iron Drugs Product and Solutions
2.2.4 Vifor Pharma IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Vifor Pharma Recent Developments and Future Plans
2.3 Akebia Therapeutics
2.3.1 Akebia Therapeutics Details
2.3.2 Akebia Therapeutics Major Business
2.3.3 Akebia Therapeutics IV and Oral Iron Drugs Product and Solutions
2.3.4 Akebia Therapeutics IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Akebia Therapeutics Recent Developments and Future Plans
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business
2.4.3 Allergan IV and Oral Iron Drugs Product and Solutions
2.4.4 Allergan IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Allergan Recent Developments and Future Plans
2.5 AMAG Pharmaceuticals
2.5.1 AMAG Pharmaceuticals Details
2.5.2 AMAG Pharmaceuticals Major Business
2.5.3 AMAG Pharmaceuticals IV and Oral Iron Drugs Product and Solutions
2.5.4 AMAG Pharmaceuticals IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 AMAG Pharmaceuticals Recent Developments and Future Plans
2.6 AOP Orphan Pharmaceuticals
2.6.1 AOP Orphan Pharmaceuticals Details
2.6.2 AOP Orphan Pharmaceuticals Major Business
2.6.3 AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Product and Solutions
2.6.4 AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 AOP Orphan Pharmaceuticals Recent Developments and Future Plans
2.7 Pharmacosmos
2.7.1 Pharmacosmos Details
2.7.2 Pharmacosmos Major Business
2.7.3 Pharmacosmos IV and Oral Iron Drugs Product and Solutions
2.7.4 Pharmacosmos IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Pharmacosmos Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi IV and Oral Iron Drugs Product and Solutions
2.8.4 Sanofi IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 Shield Therapeutics
2.9.1 Shield Therapeutics Details
2.9.2 Shield Therapeutics Major Business
2.9.3 Shield Therapeutics IV and Oral Iron Drugs Product and Solutions
2.9.4 Shield Therapeutics IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Shield Therapeutics Recent Developments and Future Plans
2.10 AZAD Pharma
2.10.1 AZAD Pharma Details
2.10.2 AZAD Pharma Major Business
2.10.3 AZAD Pharma IV and Oral Iron Drugs Product and Solutions
2.10.4 AZAD Pharma IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 AZAD Pharma Recent Developments and Future Plans
2.11 Cirondrugs
2.11.1 Cirondrugs Details
2.11.2 Cirondrugs Major Business
2.11.3 Cirondrugs IV and Oral Iron Drugs Product and Solutions
2.11.4 Cirondrugs IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Cirondrugs Recent Developments and Future Plans
2.12 MEDICE
2.12.1 MEDICE Details
2.12.2 MEDICE Major Business
2.12.3 MEDICE IV and Oral Iron Drugs Product and Solutions
2.12.4 MEDICE IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 MEDICE Recent Developments and Future Plans
2.13 Pfizer
2.13.1 Pfizer Details
2.13.2 Pfizer Major Business
2.13.3 Pfizer IV and Oral Iron Drugs Product and Solutions
2.13.4 Pfizer IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Pfizer Recent Developments and Future Plans
2.14 Salveo Lifecare
2.14.1 Salveo Lifecare Details
2.14.2 Salveo Lifecare Major Business
2.14.3 Salveo Lifecare IV and Oral Iron Drugs Product and Solutions
2.14.4 Salveo Lifecare IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Salveo Lifecare Recent Developments and Future Plans
2.15 Sunny Pharmaceutical
2.15.1 Sunny Pharmaceutical Details
2.15.2 Sunny Pharmaceutical Major Business
2.15.3 Sunny Pharmaceutical IV and Oral Iron Drugs Product and Solutions
2.15.4 Sunny Pharmaceutical IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Sunny Pharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global IV and Oral Iron Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 IV and Oral Iron Drugs Players Market Share
3.2.2 Top 10 IV and Oral Iron Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 IV and Oral Iron Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global IV and Oral Iron Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global IV and Oral Iron Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global IV and Oral Iron Drugs Revenue Market Share by Application (2016-2021)
5.2 IV and Oral Iron Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America IV and Oral Iron Drugs Revenue by Type (2016-2026)
6.2 North America IV and Oral Iron Drugs Revenue by Application (2016-2026)
6.3 North America IV and Oral Iron Drugs Market Size by Country
6.3.1 North America IV and Oral Iron Drugs Revenue by Country (2016-2026)
6.3.2 United States IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe IV and Oral Iron Drugs Revenue by Type (2016-2026)
7.2 Europe IV and Oral Iron Drugs Revenue by Application (2016-2026)
7.3 Europe IV and Oral Iron Drugs Market Size by Country
7.3.1 Europe IV and Oral Iron Drugs Revenue by Country (2016-2026)
7.3.2 Germany IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
7.3.3 France IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific IV and Oral Iron Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific IV and Oral Iron Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific IV and Oral Iron Drugs Market Size by Region
8.3.1 Asia-Pacific IV and Oral Iron Drugs Revenue by Region (2016-2026)
8.3.2 China IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
8.3.5 India IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America IV and Oral Iron Drugs Revenue by Type (2016-2026)
9.2 South America IV and Oral Iron Drugs Revenue by Application (2016-2026)
9.3 South America IV and Oral Iron Drugs Market Size by Country
9.3.1 South America IV and Oral Iron Drugs Revenue by Country (2016-2026)
9.3.2 Brazil IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa IV and Oral Iron Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa IV and Oral Iron Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa IV and Oral Iron Drugs Market Size by Country
10.3.1 Middle East & Africa IV and Oral Iron Drugs Revenue by Country (2016-2026)
10.3.2 Turkey IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE IV and Oral Iron Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global IV and Oral Iron Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global IV and Oral Iron Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market IV and Oral Iron Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global IV and Oral Iron Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global IV and Oral Iron Drugs Revenue Market Share by Region (2021-2026)
Table 6. Daiichi Sankyo Company Corporate Information, Head Office, and Major Competitors
Table 7. Daiichi Sankyo Company Major Business
Table 8. Daiichi Sankyo Company IV and Oral Iron Drugs Product and Solutions
Table 9. Daiichi Sankyo Company IV and Oral Iron Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Vifor Pharma Corporate Information, Head Office, and Major Competitors
Table 11. Vifor Pharma Major Business
Table 12. Vifor Pharma IV and Oral Iron Drugs Product and Solutions
Table 13. Vifor Pharma IV and Oral Iron Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Akebia Therapeutics Corporate Information, Head Office, and Major Competitors
Table 15. Akebia Therapeutics Major Business
Table 16. Akebia Therapeutics IV and Oral Iron Drugs Product and Solutions
Table 17. Akebia Therapeutics IV and Oral Iron Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Allergan Corporate Information, Head Office, and Major Competitors
Table 19. Allergan Major Business
Table 20. Allergan IV and Oral Iron Drugs Product and Solutions
Table 21. Allergan IV and Oral Iron Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. AMAG Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. AMAG Pharmaceuticals Major Business
Table 24. AMAG Pharmaceuticals IV and Oral Iron Drugs Product and Solutions
Table 25. AMAG Pharmaceuticals IV and Oral Iron Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. AOP Orphan Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 27. AOP Orphan Pharmaceuticals Major Business
Table 28. AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Product and Solutions
Table 29. AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Pharmacosmos Corporate Information, Head Office, and Major Competitors
Table 31. Pharmacosmos Major Business
Table 32. Pharmacosmos IV and Oral Iron Drugs Product and Solutions
Table 33. Pharmacosmos IV and Oral Iron Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sanofi Corporate Information, Head Office, and Major Competitors
Table 35. Sanofi Major Business
Table 36. Sanofi IV and Oral Iron Drugs Product and Solutions
Table 37. Sanofi IV and Oral Iron Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Shield Therapeutics Corporate Information, Head Office, and Major Competitors
Table 39. Shield Therapeutics Major Business
Table 40. Shield Therapeutics IV and Oral Iron Drugs Product and Solutions
Table 41. Shield Therapeutics IV and Oral Iron Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. AZAD Pharma Corporate Information, Head Office, and Major Competitors
Table 43. AZAD Pharma Major Business
Table 44. AZAD Pharma IV and Oral Iron Drugs Product and Solutions
Table 45. AZAD Pharma IV and Oral Iron Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Cirondrugs Corporate Information, Head Office, and Major Competitors
Table 47. Cirondrugs Major Business
Table 48. Cirondrugs IV and Oral Iron Drugs Product and Solutions
Table 49. Cirondrugs IV and Oral Iron Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. MEDICE Corporate Information, Head Office, and Major Competitors
Table 51. MEDICE Major Business
Table 52. MEDICE IV and Oral Iron Drugs Product and Solutions
Table 53. MEDICE IV and Oral Iron Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Pfizer Corporate Information, Head Office, and Major Competitors
Table 55. Pfizer Major Business
Table 56. Pfizer IV and Oral Iron Drugs Product and Solutions
Table 57. Pfizer IV and Oral Iron Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Salveo Lifecare Corporate Information, Head Office, and Major Competitors
Table 59. Salveo Lifecare Major Business
Table 60. Salveo Lifecare IV and Oral Iron Drugs Product and Solutions
Table 61. Salveo Lifecare IV and Oral Iron Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Sunny Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 63. Sunny Pharmaceutical Major Business
Table 64. Sunny Pharmaceutical IV and Oral Iron Drugs Product and Solutions
Table 65. Sunny Pharmaceutical IV and Oral Iron Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global IV and Oral Iron Drugs Revenue (USD Million) by Players (2019-2021)
Table 67. Global IV and Oral Iron Drugs Revenue Share by Players (2019-2021)
Table 68. Breakdown of IV and Oral Iron Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. IV and Oral Iron Drugs Players Head Office, Products and Services Provided
Table 70. IV and Oral Iron Drugs Mergers & Acquisitions in the Past Five Years
Table 71. IV and Oral Iron Drugs New Entrants and Expansion Plans
Table 72. Global IV and Oral Iron Drugs Revenue (USD Million) by Type (2016-2021)
Table 73. Global IV and Oral Iron Drugs Revenue Share by Type (2016-2021)
Table 74. Global IV and Oral Iron Drugs Revenue Forecast by Type (2021-2026)
Table 75. Global IV and Oral Iron Drugs Revenue by Application (2016-2021)
Table 76. Global IV and Oral Iron Drugs Revenue Forecast by Application (2021-2026)
Table 77. North America IV and Oral Iron Drugs Revenue by Type (2016-2021) & (USD Million)
Table 78. North America IV and Oral Iron Drugs Revenue by Type (2021-2026) & (USD Million)
Table 79. North America IV and Oral Iron Drugs Revenue by Application (2016-2021) & (USD Million)
Table 80. North America IV and Oral Iron Drugs Revenue by Application (2021-2026) & (USD Million)
Table 81. North America IV and Oral Iron Drugs Revenue by Country (2016-2021) & (USD Million)
Table 82. North America IV and Oral Iron Drugs Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe IV and Oral Iron Drugs Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe IV and Oral Iron Drugs Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe IV and Oral Iron Drugs Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe IV and Oral Iron Drugs Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe IV and Oral Iron Drugs Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe IV and Oral Iron Drugs Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific IV and Oral Iron Drugs Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific IV and Oral Iron Drugs Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific IV and Oral Iron Drugs Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific IV and Oral Iron Drugs Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific IV and Oral Iron Drugs Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific IV and Oral Iron Drugs Revenue by Region (2021-2026) & (USD Million)
Table 95. South America IV and Oral Iron Drugs Revenue by Type (2016-2021) & (USD Million)
Table 96. South America IV and Oral Iron Drugs Revenue by Type (2021-2026) & (USD Million)
Table 97. South America IV and Oral Iron Drugs Revenue by Application (2016-2021) & (USD Million)
Table 98. South America IV and Oral Iron Drugs Revenue by Application (2021-2026) & (USD Million)
Table 99. South America IV and Oral Iron Drugs Revenue by Country (2016-2021) & (USD Million)
Table 100. South America IV and Oral Iron Drugs Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa IV and Oral Iron Drugs Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa IV and Oral Iron Drugs Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa IV and Oral Iron Drugs Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa IV and Oral Iron Drugs Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa IV and Oral Iron Drugs Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa IV and Oral Iron Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. IV and Oral Iron Drugs Picture
Figure 2. Global IV and Oral Iron Drugs Revenue Market Share by Type in 2020
Figure 3. Oral Iron Drug
Figure 4. IVIron Drugs
Figure 5. IV and Oral Iron Drugs Revenue Market Share by Application in 2020
Figure 6. Nephrology Picture
Figure 7. OBGYN Picture
Figure 8. Surgeries Picture
Figure 9. Gastroenterology Picture
Figure 10. Oncology Picture
Figure 11. Heart failure (HF) Picture
Figure 12. Global IV and Oral Iron Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global IV and Oral Iron Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global IV and Oral Iron Drugs Revenue Market Share by Region (2016-2026)
Figure 15. Global IV and Oral Iron Drugs Revenue Market Share by Region in 2020
Figure 16. North America IV and Oral Iron Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe IV and Oral Iron Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific IV and Oral Iron Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America IV and Oral Iron Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. IV and Oral Iron Drugs Market Drivers
Figure 21. IV and Oral Iron Drugs Market Restraints
Figure 22. IV and Oral Iron Drugs Market Trends
Figure 23. Daiichi Sankyo Company Recent Developments and Future Plans
Figure 24. Vifor Pharma Recent Developments and Future Plans
Figure 25. Akebia Therapeutics Recent Developments and Future Plans
Figure 26. Allergan Recent Developments and Future Plans
Figure 27. AMAG Pharmaceuticals Recent Developments and Future Plans
Figure 28. AOP Orphan Pharmaceuticals Recent Developments and Future Plans
Figure 29. Pharmacosmos Recent Developments and Future Plans
Figure 30. Sanofi Recent Developments and Future Plans
Figure 31. Shield Therapeutics Recent Developments and Future Plans
Figure 32. AZAD Pharma Recent Developments and Future Plans
Figure 33. Cirondrugs Recent Developments and Future Plans
Figure 34. MEDICE Recent Developments and Future Plans
Figure 35. Pfizer Recent Developments and Future Plans
Figure 36. Salveo Lifecare Recent Developments and Future Plans
Figure 37. Sunny Pharmaceutical Recent Developments and Future Plans
Figure 39. Global IV and Oral Iron Drugs Revenue Share by Players in 2020
Figure 40. IV and Oral Iron Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 41. Global Top 3 Players IV and Oral Iron Drugs Revenue Market Share in 2020
Figure 42. Global Top 10 Players IV and Oral Iron Drugs Revenue Market Share in 2020
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 44. Global IV and Oral Iron Drugs Revenue Share by Type in 2020
Figure 45. Global IV and Oral Iron Drugs Market Share Forecast by Type (2021-2026)
Figure 46. Global IV and Oral Iron Drugs Revenue Share by Application in 2020
Figure 47. Global IV and Oral Iron Drugs Market Share Forecast by Application (2021-2026)
Figure 48. North America IV and Oral Iron Drugs Sales Market Share by Type (2016-2026)
Figure 49. North America IV and Oral Iron Drugs Sales Market Share by Application (2016-2026)
Figure 50. North America IV and Oral Iron Drugs Revenue Market Share by Country (2016-2026)
Figure 51. United States IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Canada IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Mexico IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Europe IV and Oral Iron Drugs Sales Market Share by Type (2016-2026)
Figure 55. Europe IV and Oral Iron Drugs Sales Market Share by Application (2016-2026)
Figure 56. Europe IV and Oral Iron Drugs Revenue Market Share by Country (2016-2026)
Figure 57. Germany IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. France IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. United Kingdom IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Russia IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Italy IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Asia-Pacific IV and Oral Iron Drugs Sales Market Share by Type (2016-2026)
Figure 63. Asia-Pacific IV and Oral Iron Drugs Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific IV and Oral Iron Drugs Revenue Market Share by Region (2016-2026)
Figure 65. China IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Japan IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South Korea IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. India IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Southeast Asia IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Australia IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South America IV and Oral Iron Drugs Sales Market Share by Type (2016-2026)
Figure 72. South America IV and Oral Iron Drugs Sales Market Share by Application (2016-2026)
Figure 73. South America IV and Oral Iron Drugs Revenue Market Share by Country (2016-2026)
Figure 74. Brazil IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Argentina IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Middle East and Africa IV and Oral Iron Drugs Sales Market Share by Type (2016-2026)
Figure 77. Middle East and Africa IV and Oral Iron Drugs Sales Market Share by Application (2016-2026)
Figure 78. Middle East and Africa IV and Oral Iron Drugs Revenue Market Share by Country (2016-2026)
Figure 79. Turkey IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. UAE IV and Oral Iron Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界の鉄剤市場規模・現状・予測（2021年-2027年） Iron is required to transport oxygen through haemoglobin in red blood cells (RBCs) and oxidize cells through cytochrome. Iron deficiency is a common cause of anaemia. Iron drugs are used to treat people with iron deficiency. In terms of geographic regions, the North Americas accounted for the major …- 世界のメルカプトプリン経口液剤市場 2021：企業別、地域別、種類・用途別 The Mercaptopurine Oral Solution Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界のメトトレキサート経口液剤市場 2021：企業別、地域別、種類・用途別 The Methotrexate Oral Solution Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界の静脈内（IV）鉄剤市場 2021：企業別、地域別、種類・用途別 The Intravenous (IV) Iron Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の経口糖尿病治療薬市場 2021：企業別、地域別、種類・用途別 The Oral Antidiabetic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…